Foreign Ministry speaker Zakharova very passionate about her dollhouseRussian Politics & Diplomacy August 18, 23:01
Modernizing Foreign Ministry's public image was a challenge — Spokeswoman ZakharovaSociety & Culture August 18, 22:24
Russian Foreign Ministry Spokeswoman Zakharova says good cigar enough to bring down stressSociety & Culture August 18, 22:19
Diplomat says story about American neo-Nazi site in Russia became political show in USRussian Politics & Diplomacy August 18, 21:07
Putin, Medvedev honor memory of Sevastopol defendersSociety & Culture August 18, 20:02
Yeltsin’s limousine put up for sale for $332,495 in St. PetersburgSociety & Culture August 18, 19:46
Sambo wrestling should become trademark of Russian sports — security officialSport August 18, 18:38
Iran may start oil supplies to Russia within monthBusiness & Economy August 18, 18:31
Nord Stream 2 project will be implemented despite sanctions — energy ministerBusiness & Economy August 18, 18:29
UNITED NATIONS, November 14. /TASS/. If the tests of experimental vaccines against the Ebola virus are successful, they will be available next year, UN Secretary-General’s special envoy David Nabarro said on Thursday. According to him, there are two highly promising potential vaccines. Sierra Leone’s Permanent Representative to the United Nations Vandi Chidi Minah told reporters that he expected “good news” about the results of the tests by the end of the current year.
According to the World Health Organization (WHO), the number of fatalities of the fever epidemic outbreak in West Africa has exceeded 5,100 people and 14,100 people have been infected. The situation is the most serious in Guinea, Liberia and Sierra Leone.
A number of countries are actively developing the Ebola vaccine. The UK, Japan, Russia and China have made progress in this area. On Wednesday, the international humanitarian organization Doctors Without Borders announced it would hold in December the vaccine testing in three medical centres in West Africa. Russia and China this week has allocated tens of millions of dollars for the development of the antiviral drugs.